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Abstract
Background: During development, all amniotes (mammals, reptiles, and birds) form extraembryonic membranes, which
regulate gas and water exchange, remove metabolic wastes, provide shock absorption, and transfer maternally derived
nutrients. In viviparous (live-bearing) amniotes, both extraembryonic membranes and maternal uterine tissues contribute to
the placenta, an endocrine organ that synthesizes, transports, and metabolizes hormones essential for development.
Historically, endocrine properties of the placenta have been viewed as an innovation of placental amniotes. However, an
endocrine role of extraembryonic membranes has not been investigated in oviparous (egg-laying) amniotes despite
similarities in their basic structure, function, and shared evolutionary ancestry. In this study, we ask whether the oviparous
chorioallantoic membrane (CAM) of chicken (Gallus gallus) has the capability to synthesize and receive signaling of
progesterone, a major placental steroid hormone.
Methodology/Principal Findings: We quantified mRNA expression of key steroidogenic enzymes involved in progesterone
synthesis and found that 3b-hydroxysteroid dehydrogenase, which converts pregnenolone to progesterone exhibited a 464
fold increase in the CAM from day 8 to day 18 of embryonic development (F5, 68=89.282, p,0.0001). To further investigate
progesterone synthesis, we performed explant culture and found that the CAM synthesizes progesterone in vitro in the
presence of a steroid precursor. Finally, we quantified mRNA expression and performed protein immunolocalization of the
progesterone receptor in the CAM.
Conclusions/Significance: Collectively, our data indicate that the chick CAM is steroidogenic and has the capability to both
synthesize progesterone and receive progesterone signaling. These findings represent a paradigm shift in evolutionary
reproductive biology by suggesting that endocrine activity of extraembryonic membranes is not a novel characteristic of
placental amniotes. Rather, we hypothesize that these membranes may share an additional unifying characteristic,
steroidogenesis, across amniotes at large.
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Introduction
A key defining characteristic of amniotes (mammals, reptiles,
and birds) is the formation of four extraembryonic membranes
during embryonic development; the amnion, chorion, allantois,
and yolk sac [1]. Fusion of the chorion and allantois forms either
the chorioallantoic placenta in viviparous (live-bearing) species, or
the chorioallantoic membrane (CAM) in oviparous (egg-laying)
species [2]. Both the chorioallantoic placenta and CAM perform
functions crucial for embryonic survival and development [1,2].
Yet, only the placenta, which is a composite structure composed of
extraembryonic membranes and maternal decidua, is classified as
an endocrine organ [2,3].
The mammalian chorioallantoic placenta synthesizes, trans-
ports, and metabolizes a suite of steroid and peptide hormones [2–
4]. Of these, placental progesterone (P4), plays a key role in the
maintenance of pregnancy [5], timing of birth [6], and promotes
growth of the embryo [7] and placenta [8,9]. Historically,
endocrine properties of the placenta have been viewed as an
innovation of eutherian mammals [2]. However, evidence of an
endocrine placenta in three species of viviparous lizards [10,11,12]
has recently called this traditional eutheriancentric view into
question.
Examination of mammalian [3,13,14] and lizard [12] placentas
has revealed that both extraembryonic membranes and maternal
tissues contribute to hormone synthesis and metabolism. There-
fore, we asked whether the extraembryonic membranes of
oviparous amniotes could also play a role in the production of
hormones during embryonic development. Although some
differences do exist in the formation of the chorionic ectoderm
between placental and oviparous amniotes [15], such an
investigation is warranted given that the extraembryonic mem-
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function that are conserved across amniota. The presence of
steroidogenic activity in the extraembryonic membranes of an
oviparous amniote would imply a more ancient origin of
endocrine function for these membranes than is currently believed.
Both the chorioallantoic placenta and CAM are derived from
chorion and allantois [2,15] Therefore, if the CAM has similar
steroidogenic properties as the chorioallantoic placenta, then it
should synthesize key placental hormones, such as P4. In this study
we examined the potential activity of P4 in the CAM of chicken
(Gallus gallus). To confirm P4 activity we must demonstrate that: (1)
the oviparous CAM has the molecular mechanisms in place to
perform steroidogenesis and synthesis of P4. Indeed, we show
mRNA expression patterns of key steroidogenic enzymes involved
in P4 biosynthesis. (2) The CAM is able to synthesize P4. We
demonstrate that in vitro P4 synthesis takes place in the CAM and is
not a product of steroids in the yolk or embryo, by isolating the
CAM from other tissues and testing for synthesis directly in the
presence of a steroid hormone precursor. (3) The CAM is capable
of receiving the P4 signal through an appropriate receptor. Again,
we demonstrate, via mRNA expression and protein immunolo-
calization of the progesterone receptor, that the CAM is capable of
modulating P4 activity.
Results
The CAM has the required molecular mechanisms to
perform steroidogenesis and synthesis of progesterone
Cholesterol is required for the de novo synthesis of steroid
hormones with steroidogenesis proceeding by the conversion of
one steroid hormone to another by the action of specific enzymes
[4]. To determine whether the oviparous CAM has the molecular
mechanisms required for P4 synthesis, we examined mRNA
expression of key steroidogenic enzymes in the steroid biosynthesis
pathway [4,16] (Figure 1). The relative levels and timing of mRNA
expression were determined by harvesting CAM tissue, which
forms on embryonic day 5, on embryonic days 8, 10, 12, 14, 16,
and 18 and performing quantitative real-time RT-PCR (RT-
qPCR) of mRNA coding for steroidogenic acute regulatory protein
(StAR), cytochrome side-chain cleavage enzyme (P450scc), 17a-
hydroxylase (P45017a), 3b-hydroxysteroid dehydrogenase (3b-
HSD), and 17b-hydroxysteroid dehydrogenase (17b-HSD).
Figure 1. Steroid biosynthesis pathway. A simplified version of steroid biosynthesis highlighting the specific steroidogenic enzymes
investigated in this study. Filled boxes highlight the steroidogenic enzymes examined by RT-qPCR. Progesterone (P4) is highlighted as the focus of
this study. First, the transport protein, steroidogenic acute regulatory protein (StAR) is needed to facilitate the movement of cholesterol from the
outer to inner mitochondrial membrane. Cholesterol is then converted to pregnenolone by the action of cytochrome side-chain cleaving enzyme
(P450scc). Pregnenolone can then be converted to either 17a-hydroxypregnenolone by 17a-hydroxylase (P45017a)o rt oP 4b y3 b-hydroxysteroid
dehydrogenase (3b-HSD). P4 can either be a final product in this pathway or serve as a precursor in the synthesis of glucocorticoids, androgens, or
estrogens. 17b-hydroxysteroid dehydrogenase (17b-HSD) functions in the conversion of weaker and stronger androgens and estrogens and was
included in this study as a marker of upstream steroid enzyme activity [4,16].
doi:10.1371/journal.pone.0005452.g001
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CAM of an oviparous amniote (Figure 2). Overall, there was
significant mRNA expression of StAR (F1, 67=65.222, p,0.0001),
P450scc (F1, 68=58.489, p,0.0001), and P45017a (F1,
66=80.004, p,0.0001); however, the level of expression did not
change significantly between embryonic day 8 and 18 for several
components of the steroidogenic pathway (StAR F5, 67=1.144,
p=0.346), (P450scc F5, 66=1.618, p=0.167), (P45017a F5,
66=1.787, p=0.128). In contrast, we observed a 464 fold increase
in 3b-HSD, which converts pregnenolone to P4, from day 8 to day
18 of development (F5, 68=89.282, p,0.0001). Detection of the
steroidogenic enzymes required for the transport and conversion
of cholesterol to P4 identifies a molecular mechanism for achieving
P4 synthesis in the CAM. Additionally, the significant increase in
3b-HSD indicates that P4 synthesis in the CAM potentially
increases through development similar to that of the chorioallan-
toic placenta through pregnancy [4,17].
In contrast, 17b-HSD showed a significant decrease in
expression, with mRNA expression decreasing to nearly zero by
day 18 (F5, 68=16.027, p,0.0001), which could be associated with
decreasing yolk androgens during development. Early in chick
development, Elf and Fivizzani [18] reported high levels of
androstenedione (A), testosterone (T), and dihydrotestosterone in
the yolk, which decreased as development proceeds. They showed
that yolk estradiol-17b remained constant through development
until increasing on embryonic day 20, which is beyond the
duration of our study. Because 17b-HSD is a key enzyme in the
conversion between A and T [19] (Figure 1), high levels of yolk A
and T earlier in embryonic development could explain why 17b-
HSD mRNA expression in the CAM was initially high and then
decreased through time. This scenario suggests that the CAM
utilizes a maternal source of androgens during development.
Taken together, these results indicate that the chick CAM has the
molecular mechanisms in place to perform steroidogenesis in
general and P4 synthesis in particular.
The CAM is capable of in vitro progesterone synthesis
Placental P4 synthesis in mammals is generally elevated from
mid to late pregnancy [17]; therefore, to investigate P4 synthesis in
the CAM, we harvested CAM tissue on embryonic day 18 and
performed in vitro explant culture. Sections of CAM were
incubated in culture media for 2, 4, or 8 hours either with or
without cholesterol (plus cAMP) as a precursor. The concentration
of P4 in the culture media was then quantified by radioimmuno-
assay. If the CAM is steroidogenic, addition of the steroid
hormone precursor (cholesterol) to the culture media should
stimulate increased P4 production. Indeed, our results showed a
significant increase in concentration of P4 in the culture media
following the addition of cholesterol precursor (F1, 58=46.917,
p,0.0001) (Figure 3). Additionally, we observed a significant
interaction between time of incubation and addition of precursor
to the culture media (F2, 58=3.709, p=0.0305). This result
Figure 2. Relative mRNA expression of steroidogenic enzymes in the chick CAM. RT-qPCR analysis of mRNA coding for StAR, P450scc,
P45017a,3 b-HSD and 17b-HSD on chick embryonic days 8 (n=10), 10 (n=17), 12 (n=14), 14 (n=10), 16 (n=14), and 18 (n=12). Data are reported as
relative mRNA expression and represent mean normalized mRNA transcript number in copies/mL6SEM. 3b-HSD increased (F5, 68=89.282, p,0.0001)
and 17b-HSD decreased (F5, 68=16.027, p,0.0001) significantly between embryonic day 8 and day 18.
doi:10.1371/journal.pone.0005452.g002
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presence of a steroid hormone precursor. Further, we found that in
the absence of precursor, the CAM produced a detectable level of
P4 that did not change significantly during the assay
(mean=34 pg/ml/g68.2 SEM, F2, 21=1.626, p=0.2205)
(Figure 3) suggesting that the CAM can exhibit endogenous P4
synthesis, but under the in vitro conditions used here this synthesis is
likely limited by the lack of precursor. In contrast, a decrease in P4
concentration during the assay would have indicated that P4
detected at the first time point was perhaps the product of
hormones leaching from this highly vascularized tissue. In sum,
these results demonstrate that the chick CAM is capable of in vitro
P4 synthesis. At present, we are unable to comment on the
bioavailability of cholesterol in the CAM under in vivo conditions
as these data do not currently exist.
The CAM is capable of receiving P4 signaling through the
progesterone receptor
Finally, we examined the capability of the chick CAM to receive
P4 signaling through an appropriate hormone receptor. As in
human [20], chick P4 receptor (PR) is predominately expressed in
two isoforms, PR-A and PR-B [21]. In chicken, the mRNA
sequences of these isoforms are identical with the exception that
PR-B has an additional 128 amino acids located at the N-terminus
[21]. To identify both PR isoforms in the CAM, we designed
primers that recognized the shared mRNA sequence (PR-ab) and
performed RT-qPCR to examine relative expression during
development. We show that PR-ab increased significantly through
embryonic development (F5, 68=15.897, p,0.0001), demonstrat-
ing a 758% increase between embryonic day 8 and 18 (Figure 4A).
We hypothesize that the observed increase in PR-ab expression in
the CAM could be due to autoregulation by P4 and/or
upregulation by an estrogen.
If CAM PR-ab is under autoregulation, i.e. P4 regulates its own
synthesis, one might expect that as 3b-HSD and presumably P4
increases, a corresponding decrease in PR-ab expression would
result [22]. However in placental tissues, P4 has been shown to
maintain and possibly upregulate PR in rats [9], and to
significantly increase the expression of PR in humans [23].
Therefore, it is possible that an increase in 3b-HSD and P4 could
result in an increase in PR-ab expression in the CAM. If CAM
PR-ab is upregulated by an estrogen, we might expect to see an
upregulation of both chick PR [24] and estrogen receptor alpha
(ERa) [25]. Therefore, we examined ERa mRNA expression in
the CAM and found that ERa increased by 307% between
embryonic day 8 and 18 (F5, 66=14.432, p,0.0001) (Fig. 4A)
suggesting that an estrogen might play a role in PR regulation.
To determine if PR-ab mRNA is translated at the level of the
protein, we performed immunolocalization of the nuclear PR with
an antibody designed to recognize both chicken A and B isoforms
[26]. We found PR-ab to be localized to the nucleus predom-
inately in the chorionic epithelium and in the epithelial cells of
mesenchymal blood vessels (Figure 4B). Positive nuclear staining
was also found in the allantoic epithelia and mesenchyme. In total,
mRNA expression and protein localization of PR-ab in the CAM
indicate that this tissue can modulate the activity of P4 during
embryonic development.
Discussion
Collectively, our data indicate that the chick CAM is
steroidogenic and has the capability to both synthesize progester-
one and receive progesterone signaling. By demonstrating mRNA
expression of steroidogenic enzymes, we show that the chick CAM
has the molecular mechanisms in place to perform steroidogenesis
and biosynthesis of P4. We demonstrate that the CAM is capable
of in vitro synthesis of P4 in the presence of a steroid precursor.
Additionally, we show that the CAM is capable of modulating P4
activity through the progesterone receptor.
In eutherian mammals, placental P4 plays a key role in the
maintenance of pregnancy [5], timing of birth [6], and promotes
growth of the embryo [7] and of the placenta itself [7–9]. Further,
P4 has been observed to stimulate blood vessel proliferation [27]
and maturation [28] in the mouse endometrium. Additionally, P4
has been suggested to play a role in human fetoplacental
vascularization by regulating the proliferation of placental vascular
smooth muscle cells [29] and through relaxation of placental blood
vessels [30]. At present, we can only speculate on the role of P4 in
the physiology of the CAM. We hypothesize that P4 in the
oviparous CAM might be expected to serve similar roles as in
eutherians contributing to the maintenance of embryonic
development, timing of hatch, and growth of the embryo and of
the CAM. Like the placenta, the CAM is a highly vascularized
organ; therefore, we suggest that P4 might be involved in CAM
blood vessel proliferation and maintenance.
Our findings represent a paradigm shift in evolutionary
reproductive biology by indicating that steroidogenic activity of
extraembryonic membranes is not a novel characteristic of
placental amniotes. Further, we hypothesize that endocrine
activity of extraembryonic membranes might be an evolutionarily
conserved characteristic of amniotes. If steroidogenic activity of
extraembryonic membranes is evolutionarily conserved, then the
endocrine role of the amniote placenta is likely to have evolved
initially in an oviparous ancestor.
Figure 3. Progesterone synthesis in the chick CAM. CAM sections
were incubated in culture media for 2, 4, or 8 hours either with (circles)
or without (squares) cholesterol (plus cAMP) as a precursor. Concen-
tration of P4 in the culture media is represented as pg/ml of P4 per g of
CAM tissue (pg/ml/g). Addition of precursor significantly increased the
concentration of P4 in the culture media (F1, 58=46.917 p,0.0001) with
a significant interaction between time of incubation and addition of
precursor (F2, 58=3.709, p=0.0305). To determine background and
cross-reactivity of the P4 assay, controls consisting of only cholesterol
and cAMP were incubated for 8 hours with an average P4 concentra-
tion of 0.337 pg/ml/g60.423 SEM (not shown).
doi:10.1371/journal.pone.0005452.g003
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amniotes are steroidogenic suggests an additional unifying
characteristic of amniotes and has implications for evolutionary
reproductive biology, particularly for the evolution of viviparity. It
is currently estimated that within squamates (lizards and snakes)
viviparity has independently evolved approximately 105 times
[31]. In the transition from oviparity to viviparity in squamates,
the period of time that eggs are retained within the uterus is
increased and the thickness of the eggshell is decreased [32].
Eggshell reduction facilitates maternal-fetal gas exchange, but has
also been proposed to function in the diffusion of chemical signals
from the embryo to the mother in order to prolong gestation [32].
Thus, secretion of steroid hormones by the oviparous CAM could
be important in establishing maternal recognition of pregnancy
during the evolution of viviparity in this group. We suggest that
evolutionary tinkering in the timing and spatial expression of
steroidogenic genes in the CAM could lead to novel endocrine
functions in communication with the maternal uterus; thus,
facilitating the endocrine role of the chorioallantoic placenta.
Materials and Methods
CAM acquisition
Fertilized chicken (Gallus gallus) eggs were obtained from Charles
River Laboratories (North Franklin, CT) and staged according to
Hamburger and Hamilton [33]. CAMs were collected by
removing the eggshell directly over the embryo and excising
CAM away from embryo and yolk sac membrane. CAMs were
washed in 16phosphate buffered saline (PBS).
RNA Isolation and reverse transcription
Dissected CAM was stored in the RNA preservative, RNAlaterH
solution (Ambion) at 4uC. Total RNA was isolated from CAM
with TRIzolH reagent (Invitrogen Life Technologies), purified with
Figure 4. PR-ab and ERa mRNA expression and PR-ab immunolocalization. (A) RT-qPCR analysis of mRNA coding for PR-ab and ERa on chick
embryonic days 8 (n=10), 10 (n=17), 12 (n=14), 14 (n=10), 16 (n=14), and 18 (n=12). Data are reported as relative mRNA expression and represent
mean normalized mRNA transcript number in copies/mL6SEM. PR-ab (F5, 68=15.897, p,0.0001) and ERa (F5, 66=14.432, p,0.0001) increased
significantly between embryonic day 8 and day 18. (B, C), PR-ab immunohistochemistry of embryonic day 18 CAM. (B) PR-ab positive section. Nuclear
staining of PR-ab is localized predominately to the chorionic epithelium (c), and epithelial cells of blood vessels (bv). Positive nuclear staining is also
present in allantoic epithelium (a), and mesenchyme (m). (C) Negative control of corresponding CAM section incubated without primary PR-ab
antibody does not show specific nuclear staining. Scale bar represents 10 microns.
doi:10.1371/journal.pone.0005452.g004
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transcribed with the iScript
TM cDNA Synthesis Kit (Bio-Rad).
Concentrations and quality of RNA samples were evaluated by
measuring optical density with a NanoDrop
TM ND-1000 (Thermo
Scientific) and by formaldehyde gel electrophoresis. Total RNA
was treated with ribonuclease-free deoxyribonuclease I (DNase I;
Qiagen) to remove any contamination of genomic DNA. 1 mgo f
total RNA was reverse transcribed and complementary DNA
(cDNA) was diluted 10-fold and stored at 220uC until RT-qPCR
analysis.
Real-time quantitative polymerase chain reaction (RT-
qPCR)
RT-qPCR analysis was performed on CAM samples from
embryonic days 8 (n=10), 10 (n=17), 12 (n=14), 14 (n=10), 16
(n=14), and 18 (n=12). cDNA was analyzed in triplicate by RT-
qPCR amplification using an iCycler MyIQ Single Color Real-
Time PCR Detection System (Bio-Rad). Each 15-mL DNA
amplification reaction contained a 10-fold dilution of 106 Gold
Buffer (Applied Biosystems), 3 mM MgCl2, 200 mM dNTPs,
0.04% Tween-20, 0.4% glycerol, 1% DMSO, 500-fold dilution of
SYBR Green (Invitrogen), 0.01 mM Fluorescein Calibration Dye
(Bio-Rad), 0.2 mM of each primer, 0.67 mL of diluted cDNA, and
0.01 U AmpliTag Gold DNA polymerase (Applied Biosystems).
RT-qPCR amplification conditions included an enzyme activation
step of 95uC (10 min) followed by 40 cycles (reference genes) or 50
cycles (target genes) of 95 C (15 sec) and a primer specific
combined annealing/extension temperature (1 min). The speci-
ficity of amplification was confirmed by melt-curve analysis.
Triplicate data for each gene were averaged and amplification
was determined by the absolute quantification method [34]. In
brief, copy numbers were calculated from the cycle threshold
(Ct) value by the linear regression of a standard curve. Standard
curves for each target gene were generated from a plasmid
containing the amplicon of interest. Controls lacking cDNA
template were included on every RT-qPCR plate to determine
the specificity of target cDNA. Additionally, to confirm that
target cDNA was not contaminated by genomic DNA, RT-
qPCR was performed with b-actin and PR-ab primers on the
RNA isolated from every sample. To normalize mRNA
expression levels, RT-qPCR was performed on all samples with
five reference genes: b-actin, GADPH, ribosomal protein L8
(RPL8), RNA polymerase II polypeptide E (POLR2E), and
ribosomal protein S13 (RPS13). The geometric mean was
calculated according to geNORM [35] generating a normaliza-
tion factor (NF) for each sample to correct for potential
differences in RNA quality or quantity. For each target gene,
absolute copy number was divided by the NF. Data are reported
as relative mRNA expression and represent mean normalized
mRNA transcript number in copies/mL6SEM.
Cloning and sequencing of plasmids
RT-qPCR of pooled cDNA was used to generate a PCR
product for each primer set. Amplified PCR products were
separated on a 2% agarose gel and visualized by ethidium bromide
on a Gel Doc EQ with Quantity One 4.6 software (Bio Rad). RT-
qPCR products were purified by WizardH SV Gel and PCR
Clean-Up System (Promega) and purified samples were confirmed
by electrophoresis on a 2% agarose gel. PCR products were cloned
into a pGEMH-T Vector System (Promega). Plasmid DNA was
purified using the WizardH Plus SV Minipreps DNA Purification
System (Promega) and sequenced on an ABI PRISMH 3100
Genetic Analyzer (Applied Biosystems) using a BigDyeH Termi-
nator v3.1 Cycle Sequencing Kits (Applied Biosystems). The
specificity of cloned DNA was confirmed using BLAST against
sequences available in Genbank. Clone DNA concentration was
quantified by NanoDrop
TM ND-1000, converted to copies/ml,
and serially diluted in a solution containing 50 mM Tris-HCl
(pH 8.3), 75 mM KCl, 3 mM MgCl2, and 5 mg/ml of tRNA.
RT–qPCR primers
All Primers were designed to amplify mRNA-specific fragments
from chicken coding sequences (NCBI) using Primer3 software
[36] and were synthesized by Eurofins MWG Operon. Primer
pairs were combined and diluted to a final concentration of
10 mM. Primer pairs are listed as forward (F), reverse (R), and the
primer specific combined annealing/extension temperature used
in RT-qPCR. RPL8-F 59-CAA CCC CGA AAC AAA GAA AA-
39,R5 9-ATA CGA CCT CCA CCA GCA AC-39 (62.4uC); b-
actin-F 59-TGC GTG ACA TCA AGG AGA AG-39,R5 9-AGA
GCT AGA GGC AGC TGT GG-39 (60.9uC); POLR2E-F 59-
ATC AAC ATC ACG GAA CAC GA-39,R5 9- GCA GCT CCG
TCA CTT CTT CT-39 (60uC); GADPH-F 59-TAT CTT CCA
GGA GCG TGA CC-39,R 59-TCT CCA TGG TGG TGA AGA
CA-39 (60uC); RPS13-F 59- AAA GGC TTG ACT CCC TCA
CA-39,R5 9-ATG TTT GCG AAC AGC AAC AG-39 (60uC);
StAR-F 59-GCC AAA GAC CAT CAT CAA CC-39,R5 9-GAC
CAA AGC ACT CAA CAG CA-39 (61.6uC); P450scc-F 59-GGT
GTC TAC GAG AGC GTG AA-39,R5 9-GTT GCG GTA GTC
ACG GTA TG-39 (64.4uC); P45017a-F 59-GAC ATC TTC CCC
TGG CTA CA-39,R5 9-CAC AGT GTC CCC ACA GAA TG-
39 (64.4uC); 3b-HSD-F 59-TCT CCA GGA AGG AGG CTT
TA-39,R5 9-GTA GAA CTG CCC CCT GAT GT-39, (62.4uC);
17b-HSD-F 59-GAG AGG GAC CAC GGT GCT GAT-39,R5 9-
AGT GGC GAA CAC TTT GAA CC-39 (64.4uC); PR-ab-F 59-
CCC AGT CTC TAA CGC AAA GG-39,R5 9-GCT CAA TGC
CTC GTA AAA CA-39 (65uC); ERa-F 59-GAT AAT AGG CGC
CAC AGC AT-39,R5 9-TAG TCG TTG CAC ACA GCA CA-39
(62.9uC).
Sexing of embryos
To sex individuals used in RT-qPCR analysis, CAM genomic
DNA was extracted from TRIzolH reagent (Zhu, Shirley, DNA
extraction from TRIZOL organic phase, http://med.stanford.
edu/labs/vanderijn/Protocols.html). DNA concentration was
determined by Nanodrop and diluted to 100 ng/mL. Molecular
sexing was performed as described in [37]. For in vitro tissue
culture, day 18 individuals were sexed by visual inspection of
embryonic gonads.
in vitro explant culture
CAMs from 7 eggs were collected on embryonic day 18. CAMs
were cut into 12 sections of approximately 0.1 g wet weight
(mean=0.104 g60.0009 SEM) allowing for duplicate sections to
undergo identical treatment regimes. CAM sections were
incubated at 37uC on an orbital shaker in L-15 culture media
(Invitrogen) either with or without cholesterol and cAMP as
precursor. Precursor solutions and concentrations are based on
King et al. 2004 [38]. For cholesterol, 22(R)-Hydroxycholesterol
(Sigma) was dissolved in 95% ethanol (Fisher) to a final
concentration of 10 mg/ml and combined with 1 mM Dibutyryl
cAMP (Sigma). After 2, 4, or 8 hours of incubation, concentration
of progesterone in the culture media was quantified by solid phase
radioimmunoassay [39]. To determine background and cross-
reactivity of the P4 assay, controls consisting of only cholesterol
and cAMP were incubated for 8 hours with an average P4
concentration of 0.337 pg/ml/g60.423 SEM.
Extraembryonic Membranes
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Dissected CAM was fixed in 4% paraformaldehyde at 4uC
overnight. Tissues were washed 36in 16PBS and stored in 75%
ethanol at 4uC. CAMs were dehydrated, paraffin embedded, and
sectioned at 8 microns. Tissue sections were deparaffinized in
citrosolv and rehydrated through graded concentrations of ethanol
to 0.1 M Tris buffered saline (TBS, pH 7.6). Immunohistochem-
istry was performed using the VectastainH Universal Quick Kit,
R.T.U. (Vector Laboratories) with the following modifications: for
antigen retrieval, slides were autoclaved for 30 min in 10 mM
sodium citrate buffer (pH 6.0). Sections were treated with 3%
hydrogen peroxide for 20 min, blocked in normal horse serum
(NHS) for 1 h, and treated with the Avidin Biotin blocking kit
(Vector Laboratories). Between all incubation steps, slides were
washed in TBS (5 min), 0.1 M TBS containing 0.2% Tween 20
(5 min), and again in TBS (5 min). CAM sections from day 16
(n=5) and day 18 (n=5) were incubated with a 1:50 dilution of
mouse monoclonal anti- progesterone receptor antibody (Ab-8),
Thermo Scientific. PR Ab-8 recognizes both PR isoforms in
chicken oviduct [26] and ovary [40]. Sections were treated with 3,
39-diaminobenzidine for 5 min (Vector Laboratories) and washed
in running tap water for 5 min. A control section receiving normal
horse serum in place of primary antibody was included on every
slide. Slides were dehydrated, cleared and mounted with
Permount
TM mounting media (Fisher Scientific). Sections were
imaged using a Leica DMRE microscope under DIC and Leica
DFC 300 FX camera with Leica Firecam software.
Statistical analysis
All statistical analyses were performed in the R statistical
programming environment version 2.8.0 [41]. For gene expression
analyses, the total numbers of mRNA transcripts for 5 control and
5 target genes from the CAM were determined by RT-qPCR. To
quantify relative expression of target genes, we divided each
sample by a normalization factor to yield normalized quantities
(copies/mL). Normalization factors were estimated as the geomet-
ric mean expression of 5 control genes using geNORM [35].
Samples displaying a non-specific melt curve were excluded from
the analysis and account for differences in number of samples
between genes. To analyze each target gene, we used linear mixed
effects models (LMMs) to estimate the parameters for relative
mRNA expression over the 6 day experiment. For each analysis,
embryonic day was treated as a fixed effect, and embryonic day,
RT-qPCR plate, and sex of individuals were treated as random
effects. Model assumptions were evaluated visually via examina-
tion of residuals and QQ plots and square-root transformations
were performed when necessary to normalize errors (all genes
were square root transformed except P45017a which did not
require transformation). Outliers were identified from residuals
and QQ plots and removed from the study (note that inclusion of
outliers did not change patterns of significance, but were excluded
from the final analysis because they have a disproportionate
influence on mean estimates and caused violations of normality).
The assumption of homogeneity of variances was met for all genes
except 3b-HSD, which is likely due to the substantial changes in
mean expression of 3b-HSD as the embryo developed. Thus for
3b-HSD variance was assumed to be a power of the estimated
mean for each day and the exponent was estimated from the data
as part of the estimation procedure [42]
For in vitro tissue culture, we used the same analytical approach
described above using a LMM to estimate P4 concentration in
culture media. In this analysis treatment (precursor versus control)
and time (hour) are fixed effects on P4 concentrations (pg/ml/g of
CAM tissue) and day of dissection, egg, replicate and sex of
individual were treated as random effects. P4 concentration was
square root transformed and two outliers, the largest value for
control at 4 hours (206) and the largest value for precursor at
8 hours (213) were excluded from the analysis as outliers.
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